Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

被引：0
|
作者：
Joshua Z Press
Alessandro De Luca
Niki Boyd
Sean Young
Armelle Troussard
Yolanda Ridge
Pardeep Kaurah
Steve E Kalloger
Katherine A Blood
Margaret Smith
Paul T Spellman
Yuker Wang
Dianne M Miller
Doug Horsman
Malek Faham
C Blake Gilks
Joe Gray
David G Huntsman
机构：
[1] University of British Columbia,Department of Obstetrics and Gynecology
[2] University of British Columbia,Department of Pathology and Laboratory Medicine
[3] Hereditary Cancer Program,Genetic Pathology Evaluation Centre of the Prostate Centre
[4] British Columbia Cancer Agency,Life Sciences Division, Lawrence Berkeley National Laboratory
[5] Vancouver General Hospital,Department of Gynecologic Oncology
[6] Molecular Genetics,undefined
[7] The Royal Melbourne Hospital,undefined
[8] University of California,undefined
[9] Affymetrix Inc,undefined
[10] University of British Columbia,undefined
来源：
BMC Cancer | / 8卷
关键词：
Ovarian Cancer; Ovarian Carcinoma; BRCA1 Mutation; Promoter Hypermethylation; BRCA1 Promoter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas
    Walsh, Christine S.
    Ogawa, Seishi
    Scoles, Daniel R.
    Miller, Carl W.
    Kawamata, Norihiko
    Narod, Steven A.
    Koeffler, H. Phillip
    Karlan, Beth Y.
    CLINICAL CANCER RESEARCH, 2008, 14 (23) : 7645 - 7651
  • [22] High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations
    Rzepecka, Iwona K.
    Szafron, Lukasz
    Stys, Agnieszka
    Bujko, Mateusz
    Plisiecka-Halasa, Joanna
    Madry, Radoslaw
    Osuch, Beata
    Markowska, Janina
    Bidzinski, Mariusz
    Kupryjanczyk, Jolanta
    CANCER GENETICS, 2012, 205 (03) : 94 - 100
  • [23] BRCA1 - Genetic testing and hereditary breast and ovarian cancer
    Ross, DW
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1997, 121 (07) : 754 - 755
  • [24] Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
    Weren, Robbert D. A.
    Mensenkamp, Arjen R.
    Simons, Michiel
    Eijkelenboom, Astrid
    Sie, Aisha S.
    Ouchene, Hicham
    van Asseldonk, Monique
    Gomez-Garcia, Encarna B.
    Blok, Marinus J.
    de Hullu, Joanne A.
    Nelen, Marcel R.
    Hoischen, Alexander
    Bulten, Johan
    Tops, Bastiaan B. J.
    Hoogerbrugge, Nicoline
    Ligtenberg, Marjolijn J. L.
    HUMAN MUTATION, 2017, 38 (02) : 226 - 235
  • [25] Epigenetic tumor suppression by BRCA1
    Aneliya Velkova
    Alvaro N A Monteiro
    Nature Medicine, 2011, 17 : 1183 - 1185
  • [26] Inactivation of BRCA1 by epigenetic gene silencing in human ovarian tumors.
    Kawakami, Y.
    Miyamoto, K.
    Takehara, K.
    Nakamura, H.
    Samura, O.
    Mizunoe, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Epigenetic tumor suppression by BRCA1
    Velkova, Aneliya
    Monteiro, Alvaro N. A.
    NATURE MEDICINE, 2011, 17 (10) : 1183 - 1185
  • [28] Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression
    Wang, Yan-Qiu
    Yan, Qin
    Zhang, Jia-Rong
    Li, Shuang-Di
    Yang, Yi-Xia
    Wan, Xiao-Ping
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2013, 39 (02) : 549 - 554
  • [29] Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer
    Daniels, Molly S.
    Urbauer, Diana L.
    Stanley, Jennifer L.
    Johnson, Kristin G.
    Lu, Karen H.
    GENETICS IN MEDICINE, 2009, 11 (09) : 624 - 628
  • [30] Secondary BRCA1/2 mutations are associated with platinum resistance in a large series of BRCA1/2-mutated ovarian carcinomas
    Norquist, B.
    Sakai, W.
    Wurz, K.
    Karlan, B.
    Taniguchi, T.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S4 - S4
12345